Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
Abstract
Although ovarian clear cell carcinomas (OCCC) are commonly resistant to platinum-based chemotherapy, good clinical outcomes are observed in a subset of patients. The explanation for this is unknown but may be due to misclassification of high-grade serous ovarian cancer (HGSOC) as OCCC or mixed histology.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 01, 2019
- Source ID
- 10.1158/1078-0432.ccr-18-3691
Entities
People
- Ahwan Pandey
- Aikou Okamoto
- Ayako Kawabata
- Daito Noguchi
- Dale W Garsed
- Dane Vassiliadis
- Dariush Etemadmoghadam
- David D. L. Bowtell
- Gisela Mir Arnau
- Hirokuni Takano
- Hiroyuki Takahashi
- Jason Li
- Joy Hendley
- Kaushalya C Amarasinghe
- Kazuhiko Ochiai
- Martin Köbel
- Masahiro Ikegami
- Masataka Takenaka
- Michael Friedlander
- Nadia Traficante
- Nozomu Yanaihara
- Seiji Isonishi
- Sian Fereday
- Sreeja Gadipally
- Takako Kiyokawa
- Timothy Semple
Organizations
- Jikei University School of Medicine
- National Health and Medical Research Council
- United States Army Medical Research and Development Command
- University of Calgary
- University of Melbourne
- University of New South Wales